Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Minority enrollment in Parkinson's disease clinical trials.
Schneider MG, Swearingen CJ, Shulman LM, Ye J, Baumgarten M, Tilley BC. Schneider MG, et al. Among authors: swearingen cj. Parkinsonism Relat Disord. 2009 May;15(4):258-62. doi: 10.1016/j.parkreldis.2008.06.005. Epub 2008 Aug 9. Parkinsonism Relat Disord. 2009. PMID: 18693062 Free PMC article.
Caffeine and progression of Parkinson disease.
Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC; NET-D Investigators. Simon DK, et al. Among authors: swearingen cj. Clin Neuropharmacol. 2008 Jul-Aug;31(4):189-96. doi: 10.1097/WNF.0b013e31815a3f03. Clin Neuropharmacol. 2008. PMID: 18670242 Free PMC article. Clinical Trial.
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.
Parashos SA, Swearingen CJ, Biglan KM, Bodis-Wollner I, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators. Parashos SA, et al. Among authors: swearingen cj. Arch Neurol. 2009 Sep;66(9):1099-104. doi: 10.1001/archneurol.2009.159. Epub 2009 Jul 13. Arch Neurol. 2009. PMID: 19597081 Free PMC article. Clinical Trial.
MBDA: what is it good for?
Yazici Y, Swearingen CJ. Yazici Y, et al. Ann Rheum Dis. 2014 Nov;73(11):e72. doi: 10.1136/annrheumdis-2014-206252. Epub 2014 Jul 23. Ann Rheum Dis. 2014. PMID: 25057179 No abstract available.
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro Gda R, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T; QUEST-RA Group. Sokka T, et al. Arthritis Res Ther. 2009;11(1):R7. doi: 10.1186/ar2591. Epub 2009 Jan 14. Arthritis Res Ther. 2009. PMID: 19144159 Free PMC article.
139 results